This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Karayiannis, P. Articles by Thomas, H. C. Search for Related Content PubMed PubMed Citation Articles by Karayiannis, P. Articles by Thomas, H. C.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, Nov 1995, 708-711, Vol 2, No. 6
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Recombinant vaccinia viruses expressing hepatitis A virus structural polypeptides: detection of an anti-VP0 response in convalescent-phase sera

P Karayiannis, S O'Rourke, R Watts, J Waters, V Hill, WF Carman and HC Thomas
Department of Medicine, St. Mary's Hospital Medical School, Imperial College of Science, Technology and Medicine, London, United Kingdom. P.Karayiannis@sm.ic.ac.uk

We have generated a number of recombinant vaccinia viruses which expressed the hepatitis A virus (HAV) structural polypeptides VP1, VP2, VP3, and VP4, either alone or in combination. The relevant sequences encoding these polypeptides were amplified from cloned cDNA by PCR and then cloned into the insertion vector pGS62. The presence of the HAV structural polypeptide-encoding sequences in the recombinant viruses was confirmed by Southern blot analysis, whilst their transcription and translation were demonstrated by Northern (RNA) blot analysis and immunodetection, respectively. Immunoprecipitation studies using these constructs have detected the presence of an anti-VP0 response in human convalescent sera following HAV infection. The significance of this finding and the usefulness of these constructs in studying cell- mediated immunity during recovery from HAV infection are discussed.